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Abstract  Intrathecal  chemoprophylaxis  prevents  central  nervous  system  relapses  in  patients
with acute  lymphoblastic  leukaemia  (ALL)  but  few  studies  have  addressed  the  predictive  mark-
ers of  relapse.  Among  these,  traumatic  lumbar  puncture  (TLP)  has  been  associated  with  lower
disease-free  survival  (DFS).
To  investigate  the  risk  posed  by  TLP  on  relapse  and  DFS,  we  assembled  a  retrospective  cohort
including  79  patients  with  ALL  who  received  intrathecal  chemoprophylaxis  during  2009  to  2013.
One TLP  per  patient  was  recorded  in  49  cases,  and  more  than  one  TLP  in  3.  Mean  follow-up  was
283 (22--1118)  days  with  an  overall  DFS  of  68%.  DFS  was  signiﬁcantly  lower  in  the  group  that
had experienced  TLP  (58%  vs  100%  [P  =  .070]).  Multiple  TLP  posed  a  greater  risk  of  relapse  than
single TLP  (P  =  .001).  In  conclusion,  TLP  in  adults  constitutes  a  major  risk  factor,  greater  than
that reported  in  the  large  paediatric  series.
© 2015  Published  by  Masson  Doyma  México  S.A.  on  behalf  of  Sociedad  Médica  del  Hospital
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Resumen  La  quimioproﬁlaxis  intratecal  evita  la  recaída  a  sistema  nervioso  central  en
pacientes  con  leucemia  linfoblástica  aguda  (LAL),  aunque  poco  se  ha  estudiado  sobre∗ Corresponding author at: Dr. Balmis 148, Col. Doctores, C.P. 06726, Mexico City, Mexico.
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marcadores  predictivos  de  recaída.  Entre  estos,  la  punción  lumbar  traumática  (TLP)  se  ha
asociado con  una  menor  supervivencia  libre  de  la  enfermedad  (EFS).
Para investigar  el  riesgo  que  inﬁere  la  TLP  sobre  la  recaída  y  la  EFS,  se  formó  una  cohorte
retrospectiva  compuesta  por  79  pacientes  con  LAL  que  recibieron  quimioproﬁlaxis  intratecal
durante  2009  a  2013.  Se  registró  una  TLP  por  paciente  en  49  casos  y  más  de  una  en  3.  La  media
de seguimiento  fueron  283  (22--1118)  días,  con  EFS  global  del  68%,  signiﬁcativamente  menor
en quienes  recibieron  alguna  TLP  (58%  vs  100%  [p  =  0.070]).  Múltiples  TLP  aportaron  mayor
riesgo que  TLP  única  (p  =  0.001).  En  conclusión,  las  TLP  en  adultos  son  un  factor  de  riesgo
preponderante,  con  mayor  relevancia  de  lo  reportado  en  las  grandes  series  pediátricas.
© 2015  Publicado  por  Masson  Doyma  México  S.A.  en  nombre  de  Sociedad  Médica  del  Hospital
General de  México.
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At  present  acute  lymphoblastic  leukaemia  with  B  or  T
precursors  is  treated  using  block  sequential  chemotherapy
regimens  in  conjunction  with  immunotherapy  and  tyrosine
kinase  inhibitors,  and  unlike  other  leukaemias,  it  requires
prophylaxis  therapy  due  to  the  high  risk  of  central  ner-
vous  system  relapse.1--4 In  its  infancy,  prophylaxis  consisted
of  radiation  therapy  to  the  head  followed  by  high  doses
of  methotrexate  plus  intrathecal  chemotherapy.  Most  of
our  knowledge  on  prophylaxis  and  relapse  has  been  gained
from  paediatric  protocols.  Conter  and  collaborators  in  the
AIEOP  group  substituted  chemotherapy  for  a  regime  of  high
doses  of  intrathecal  methotrexate  (5  g/m2 for  four  courses)
and  achieved  a  relapse-free  survival  of  above  90%,  recor-
ding  a  recurrence  rate  of  only  5%.5 This  strategy  has  been
validated  by  other  authors  around  the  world  with  similar
relapse  rates,6,7 and  therefore  intrathecal  chemotherapy
became  the  standard  prophylaxis  therapy  for  the  central
nervous  system  (CNS),  the  triple  combination  strategy  being
the  most  popular.8 There  are  few  studies  in  adults  in  this
regard,  and  most  of  them  agree  that  adequate  prophy-
laxis  prevents  CNS  relapse.9 There  are  also  few  predictive
markers  of  relapse.  Sancho  and  collaborators  only  managed
to  identify  lactate-dehydrogenase  as  a  predictive  marker
of  relapse.10 Traumatic  lumbar  puncture  as  a  CNS  relapse
risk  is  another  factor  of  interest.  In  general,  most  series
agree  that  the  presence  of  traumatic  cerebrospinal  ﬂuid
with  blasts  shortens  relapse-free  survival  and  that  CNS1  and
CNS2  liquids  behave  similarly.11,12 In  our  hospital,  triple-drug
therapy  (cytarabine,  methotrexate  and  hydrocortisone)  has
been  effective  in  controlling  isolated  CNS  relapses.13 This
is  because  our  institutional  protocol  uses  intensive  doses
of  intrathecal  chemotherapy,  and  the  objective  proposed
was  to  establish  whether  there  is  an  association  between
traumatic  lumbar  puncture  and  the  risk  of  CNS  relapse.
Patients and methods
Protocol  designAn  observational  study  based  on  a  retrospective  cohort
of  patients  with  de  novo  acute  lymphoblastic  leukaemia
treated  in  the  haematology  department  of  the  General
C
e
dospital  of  Mexico  between  December  2009  and  July
013.  These  patients  had  received  ﬁrst-line  treatment  and
rophylaxis  directed  at  the  central  nervous  system  using
ntrathecal  chemotherapy.  Patients  who  were  to  receive
adiotherapy  or  who  did  not  have  basal  cerebrospinal  ﬂuid
or  analysis  were  excluded  from  the  study.
reatment
nstitutional  protocol  HGMLAL07  has  been  available  in  our
ospital  from  2007  to  the  present  date  as  ﬁrst-line  treatment
or  patients  with  adult  acute  lymphoblastic  leukaemia.  This
rotocol  includes  a  pre-induction  phase  with  steroids  simi-
ar  to  protocol  GIMEMA  ALL0087  and  intensiﬁcation  phases
uring  the  maintenance  phase.  Central  nervous  system-
irected  prophylaxis  was  given  in  four  doses  of  intrathecal
hemotherapy  during  the  induction  of  remission  phase,  fol-
owed  by  monthly  doses  during  the  six  consolidation  blocks
nd  then  bimonthly  doses  over  the  2  years  of  maintenance.
he  chemotherapy  regimen  included  15  mg  methotrexate,
0  mg  cytarabine  and  8  mg  dexamethasone.  The  patients
ho  were  treated  with  the  Hyper-CVAD  regimen  received
hemotherapy  on  days  2  and  8  of  each  course  with  15  mg
ethotrexate  and  100  mg  cytarabine  respectively.
The  cerebrospinal  ﬂuid  was  examined  by  cytospin
ROTOFIX  32  A,  ZENTRIFUGEN  brand  at  6000  rpm),  it  was
hen  stained  with  Wright--Giemsa  and  examined  at  increases
f  10×  and  100×.
The  status  for  considering  central  nervous  system
nﬁltration  was  based  on  the  following  criteria:  CNS1,  non-
raumatic  lumbar  puncture  (<10  erythrocytes/L);  CNS2,
on-traumatic  lumbar  puncture  with  a  white  blood  cell
ount  of  less  than  5  L  and  blasts  in  the  cerebrospinal
uid;  CNS3,  non-traumatic  lumbar  puncture  with  >5  white
lood  cells  and  blasts  in  the  CSF.  For  the  statistical  anal-
sis,  it  was  considered  traumatic  ﬂuid  (TLP)  if  it  had  >10
rythrocytes/L  and  lumbar  puncture  with  inﬁltration  if
lasts  were  present  in  the  cerebrospinal  ﬂuid.
tatistical  analysisentral  nervous  system  relapse-free  survival  was  consid-
red  from  the  date  of  diagnosis  until  the  date  of  relapse,
eath  or  the  last  date  recorded  on  the  medical  record.
1 G.  Barranco-Lampón  et  al.
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he  Kaplan--Meier  method  was  used  for  distribution  and  the
wo  groups  were  subsequently  compared  using  the  Log-Rank
est.  The  factors  that  might  inﬂuence  central  nervous  sys-
em  relapse  were  analysed  using  Cox  regression  analysis.
he  hypothesis  contrast  test  was  performed  using  the  chi
quare  test,  a  value  of  ≤0.05  being  considered  signiﬁcant,
nalysed  at  a  95%  conﬁdence  interval.  The  entire  analysis
as  performed  using  IBM  SPSS  Statistics  for  Windows  version
0.0  (Armonk,  New  York).
thical  considerations
his  study  has  been  approved  by  the  ethics  and  research
ommittees  of  the  General  Hospital  of  Mexico.
esults
atients  included  in  both  the  institutional  protocol  HGM-
AL07  and  the  Hyper-CVAD  regimen  were  studied  from
ecember  2009  to  July  2013.  Twelve  patients  were  excluded
rom  the  study  because  they  had  a  sample  from  follow-
p  but  no  sample  of  cerebrospinal  ﬂuid  from  diagnosis.
9  patients  were  studied  for  the  ﬁnal  analysis.  The  mean
ollow-up  of  the  patients  was  315  days  (range  of  22--1118
ays).  After  analysis  of  cerebrospinal  ﬂuid  at  the  time  of
iagnosis,  central  nervous  system  inﬁltration  was  recorded
n  only  one  case  (1.3%).  On  diagnosis,  the  mean  white  blood
ell  count  was  40.86  ×  103/mcl,  when  the  cases  were  divided
nly  15.2%  (n  =  12)  of  the  patients  had  a  white  blood  cell
ount  of  more  than  100  ×  103/mcl  at  the  time  of  diagno-
is,  and  in  general  the  majority  of  the  patients  had  counts
f  less  than  30  ×  103/mcl  (64.6%).  The  mean  age  was  31
range  from  16  to  65)  the  majority  being  patients  under  35
67.1%).  All  the  patients  were  classiﬁed  according  to  the
ype  of  risk  of  early  relapse  (age  <35,  white  blood  count
30  ×  103/mcl,  central  nervous  system  inﬁltration  on  diag-
osis,  expression  of  Philadelphia  chromosome,  resistance
fter  4  weeks  of  treatment).  Of  the  79  patients,  46.8%
n  =  37)  were  considered  usual  risk  and  53.2%  (n  =  42)  high
isk.  Immunophenotyping  on  diagnosis  showed  that  89.9%
n  =  71)  of  cases  corresponded  to  a  precursor  B  and  10.1%
n  =  8)  to  a  precursor  T  lymphoblastic  leukaemia.  Contrary
o  expectations,  the  mean  white  blood  cell  count  in  T
eukaemias  was  lower  compared  to  the  B  leukaemias  (14.11
s  43.85  ×  103/mcl)  but  this  difference  is  not  signiﬁcant
P  =  .235,  95%  Conﬁdence  Interval).
Association  between  traumatic  lumbar  puncture  and
entral  nervous  system  relapse.  The  mean  of  the  ﬂuids  col-
ected  as  part  of  the  central  nervous  system  prophylaxis
rotocol  was  7  (range  1--32  punctures),  and  at  least  one
raumatic  puncture  was  recorded  in  64.6%  of  cases  (n  =  51).
hen  the  cases  were  divided,  62%  (n  =  49)  had  experienced
ne  single  traumatic  lumbar  puncture  and  3.8%  (n  =  3)  more
han  one  traumatic  lumbar  puncture  during  the  follow-up
rotocol.  A  total  of  8  cases  of  central  nervous  system  inﬁl-
ration  were  recorded  during  follow-up  (10.1%).  The  2 test
howed  a  statistically  signiﬁcant  result  between  the  pres-
nce  of  a  traumatic  puncture  and  central  nervous  system
elapse  (P  =  .024,  95%  CI).
Relapse-free  survival  (RFS)  between  the  groups.  The
ean  relapse-free  survival  (RFS)  for  this  cohort  was  68%
c
p
m
iigure  1  Disease-free  survival  in  patients  with  traumatic  and
on-traumatic  lumbar  punctures.
mean  follow-up  283  days,  range  22--1118  days).  When  the
entral  nervous  system  relapse-free  survival  rates  between
he  two  groups  (traumatic  and  non-traumatic)  were  estab-
ished,  those  who  had  experienced  a  traumatic  puncture  had
ower  RFS  compared  to  those  who  had  experienced  a  non-
raumatic  lumbar  puncture  (100%  vs  58%).  The  difference
as  established  using  the  Log-Rank  test,  the  P  value  being
 =  .070  (Fig.  1).
Association  between  different  factors  and  central  ner-
ous  system  relapse.  A  model  was  created  to  determine
hether  traumatic  lumbar  punctures  represented  a  risk  of
entral  nervous  system  relapse,  considering  the  risk  of  the
resence  of  a  single  traumatic  lumbar  puncture  or  multi-
le  traumatic  lumbar  punctures  (two  or  more  punctures)
hroughout  the  entire  follow-up.  Other  variables  were  also
onsidered  such  as  the  white  blood  cell  count  on  diagnosis
30  vs  100  ×  103/mcl),  age  (limit  of  35)  along  with  the  risk
f  bone  marrow  relapse  after  a  traumatic  lumbar  puncture.
he  main  risk  was  established  in  patients  with  traumatic
umbar  punctures  but  it  was  considerably  greater  in  patients
ho  had  experienced  multiple  traumatic  punctures.  The
dds  ratio  results  are  shown  in  Table  1. The  odds  ratio  value
f  traumatic  lumbar  puncture  on  bone  marrow  relapse  is
.2963;  this  is  not  statistically  signiﬁcant  (P  =  035,  95%  CI
range  0.40--13.16]).
A Cox  regression  analysis  was  used  to  assess  the  inﬂuence
f  the  different  variables  on  relapse-free  survival  consider-
ng  all  the  risk  variables  and  the  two  types  of  traumatic  CSF
single  or  multiple  traumatic  CSF).  Both  traumatic  lumbar
uncture  and  multiple  traumatic  punctures  were  the  two
ariables  that  presented  a greater  risk  of  central  nervous
ystem  relapse.  Table  2  shows  the  summary  of  the  model.
iscussion
eukaemic  inﬁltration  of  the  CNS  is  one  of  the  main
omplications  associated  with  the  treatment  of  acute  lym-
hoblastic  leukaemia.  Although  ﬂow  cytometry  can  identify
onoclonal  B-cells  in  up  to  0.01%  of  the  entire  population,
t  is  not  yet  a  validated  test,  and  morphological  analysis  of
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Table  1  Multivariable  analysis  of  the  risk  factors  for  central  nervous  system  relapse.
Variable  Odds  ratio  Range  (95%  conﬁdence  interval)  Z  value  P  value
Traumatic  lumbar  puncture 11.1379 0.6183--200.6219  1.634  .024*
Multiple traumatic  puncture  56.6364  2.5698--1248.23  2.558  .003*
White blood  cells  >30  ×  103/mcl  0.5769  0.1084--3.0698  0.645  .250
White blood  cells  >100  ×  103/mcl  0.2800  0.0152--51744  0.855  .410
Age >35  1.2522  0.2752--5.6980  0.291  .526
Table  2  Cox  regression  analysis  of  the  risk  factors,  taking  CNS  relapse  as  the  ﬁnal  event.
Variable  Exp(B)  Sig.
High  versus  usual  risk  1.723  .460  0.407--7.297
Phenotype T  vs  phenotype  B  0.380  .560  0.000--579.4
Multiple traumatic  puncture  vs  traumatic  puncture 57.099  .001* 5.750--567.03
Traumatic puncture  vs  non-traumatic  puncture 35.691 .281  0.53--24,124.9
Age (>35  vs  <35) 2.248  .306  0.477--10.581
White blood  cells  (>100  vs  <100  ×  103/mcl) 0.041 .511  0.000--565.85
b
h
i
t
l
a
p
f
9
w
w
t
s
f
l
s
l
a
F
N
C
T
R* Statistically signiﬁcant.
cerebrospinal  ﬂuid  is  used  instead.14,15 It  has  been  difﬁcult  to
identify  markers  to  predict  central  nervous  system  relapse,
in  general  only  DHL  >1000  U/L  or  a  high  tumour  load  on  diag-
nosis  have  been  identiﬁed  as  predictive  markers.10,5 Some
authors  suggest  that  markers  that  express  normally  in  CSF
may  also  be  useful.  One  of  these  is  osteoprotegerin,  a cyto-
sine  receptor  that  is  a  member  of  the  superfamily  of  tumour
necrosis  factor  receptors,16 and  it  has  also  been  isolated  in
leukaemia  and  myeloma  cell  lines.17 Other  cell  markers  are
surface  markers.  Cannizzo  and  collaborators  identiﬁed  the
expression  of  CD56+  in  a  case  of  isolated  CNS  relapse,18 like
Matsubara  and  collaborators  who  also  found  the  expression
of  this  marker,  but  in  bone  marrow  blasts  at  the  time  of
diagnosis.19,20 Because  it  is  difﬁcult  to  identify  any  useful
marker,  there  is  major  interest  now  in  the  risk  associated
with  traumatic  lumbar  puncture  and  central  nervous  system
relapse.  Howard  and  collaborators  analysed  around  5609
lumbar  puncture  procedures  in  St  Jude  Children’s  Research
Hospital,  and  identiﬁed  both  modiﬁable  and  non-modiﬁable
risk  factors  for  the  presence  of  a  traumatic  lumbar  punc-
ture,  the  latter  included  being  of  black  ethnicity  and  aged
under  1  year,  and  the  main  modiﬁable  factors  are  a  history
of  lumbar  puncture  2  weeks  earlier  performed  by  a  trained
doctor  and  with  adequate  transfusion  support,  primarily
with  a  count  lower  than  50  ×  103/mcl.21 The  hypothesis  that
leukaemic  cells  might  implant  in  the  meninges  has  already
been  corroborated  in  in  vivo  models.  Barone  and  collab-
orators  injected  leukaemic  T  cells  intrathecally  in  their
experimental  model  in  rats.  The  histopathological  study  of
the  rats,  sacriﬁced  between  days  1  and  11  after  injection
of  the  leukaemic  cells,  showed  a  highly  dispersed  pattern  of
leukaemic  cells  throughout  the  entire  subarachnoid  space,
brain  and  cerebellum.  This  was  greater  in  the  rats  sacri-
ﬁced  on  day  11  post-injection.  Between  28%  and  100%  of  the
animals  also  showed  molecular  expression  of  the  leukaemic
cells.22 Perhaps  the  most  signiﬁcant  ﬁnding  was  the  capac-
ity  of  the  blasts  to  invade  the  subarachnoid  space  as  well  as
the  Virchow--Robin  space.  This  is  of  major  signiﬁcance  sincelasts  that  are  introduced  and  scattered  via  lumbar  puncture
ave  a  capacity  to  proliferate  and  invade  which  is  very  sim-
lar  to  bone  marrow.  Therefore  various  series  establish  that
raumatic  lumbar  punctures  with  blasts  are  associated  with
ower  relapse-free  survival.  Similarly  to  our  study,  Shaikh
nd  collaborators  analysed  cases  with  traumatic  lumbar
unctures  with  blasts,  and  identiﬁed  a  decreased  relapse-
ree  survival  compared  to  those  with  sterile  liquids  (77%  vs
3%),  but  unlike  our  study,  a history  of  a  traumatic  puncture
as  found  not  to  pose  as  much  risk  (1.43  vs  56.6).23 This  is
hy  it  is  increasingly  being  recommended  that  lumbar  punc-
ure  should  not  be  take  place  at  the  time  of  diagnosis  but
hould  be  performed  when  circulating  blasts  are  no  longer
ound  (e.g.  day  8  or  day  9).24--26
In  conclusion,  knowledge  on  acute  lymphoblastic
eukaemia  has  been  gained  from  paediatric  protocols,  divi-
ion  of  risk,  early  intensiﬁcation,27 and  now  traumatic
umbar  punctures  constitute  strategies  to  enable  improved
dult  protocols.
unding
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